20/20 Biolabs, Inc.
Datakwaliteit: 100%
AIDX
Nasdaq
Services
Engineering & Management Services
€ 1,90
▼
€ 0,02
(-0,78%)
Marktkapitalisatie: 19,84 M
Prijs
€ 1,90
Marktkapitalisatie
19,84 M
Dagbereik
€ 1,73 — € 1,99
52-Weeksbereik
€ 1,51 — € 50,00
Volume
55.543
Openen € 1,87
50D / 200D Gem.
€ 4,01
52,56% below
50D / 200D Gem.
€ 4,01
52,56% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -1,92 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-157,17%
Net Margin-182,82%
Op. Margin-162,87%
Veiligheid
Debt / Equity
N/A
Current Ratio0,60
Interest Coverage-21,32
Waardering
PE (TTM)
-5,31
Onder sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (502 peers)
Sectorvergelijking
vs Services sector mediaan (502 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -5,3 | -1,2 |
| P/B | — | 1,4 |
| ROE % | — | -16,0 |
| Net Margin % | -182,8 | -19,4 |
| Rev Growth 5Y % | — | 4,0 |
| D/E | — | 0,4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,05 M | Net Income (TTM) | -3,74 M |
| ROE | N/A | ROA | -90,37% |
| Gross Margin | 29,56% | Operating Margin | -162,87% |
| Net Margin | -182,82% | Free Cash Flow (TTM) | -1,92 M |
| ROIC | -157,17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,60 |
| Interest Coverage | -21,32 | Asset Turnover | 0,49 |
| Working Capital | -992.008 | Tangible Book Value | -221.489 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -5,31 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 9,70 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -9,68% | ||
| Market Cap | 19,84 M | Enterprise Value | 18,82 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,76 | Revenue / Share | 0,20 |
| FCF / Share | -0,18 | OCF / Share | -0,18 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 51,35% |
| SBC-Adj. FCF | -2,44 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 |
|---|---|
| Revenue | 2,05 M |
| Net Income | -3,74 M |
| EPS (Diluted) | -0,76 |
| Gross Profit | 604.541,0 |
| Operating Income | -3,33 M |
| EBITDA | — |
| R&D Expenses | 592.569,0 |
| SG&A Expenses | 3,34 M |
| D&A | 63.257,0 |
| Interest Expense | 156.207,0 |
| Income Tax | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 |
|---|---|
| Total Assets | 4,14 M |
| Total Liabilities | 4,16 M |
| Shareholders' Equity | -19.225,0 |
| Total Debt | — |
| Cash & Equivalents | 1,03 M |
| Current Assets | 1,47 M |
| Current Liabilities | 2,46 M |
{"event":"ticker_viewed","properties":{"ticker":"AIDX","listing_kind":"stock","pathname":"/stocks/aidx","exchange":"Nasdaq","country":"US"}}